The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age
Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphin...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Sage Science Press
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/26075 |
| _version_ | 1848751882745413632 |
|---|---|
| author | Gower, Shelley Bartu, Anne Ilett, K. Doherty, D. McLaurin, R. Hamilton, D. |
| author_facet | Gower, Shelley Bartu, Anne Ilett, K. Doherty, D. McLaurin, R. Hamilton, D. |
| author_sort | Gower, Shelley |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Further research using larger samples to assess possible developmental effects over longer periods of time is required. |
| first_indexed | 2025-11-14T07:59:47Z |
| format | Journal Article |
| id | curtin-20.500.11937-26075 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T07:59:47Z |
| publishDate | 2014 |
| publisher | Sage Science Press |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-260752017-09-13T15:25:12Z The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age Gower, Shelley Bartu, Anne Ilett, K. Doherty, D. McLaurin, R. Hamilton, D. substance abuse drug-exposed infants infant health breastfeeding Background: Buprenorphine has been available in Australia since 2000 as an alternative pharmacotherapy to methadone for the treatment of opioid dependence. However, there is little information in the literature regarding the effect of buprenorphine on the wellbeing of infants exposed to buprenorphine via breast milk, following discharge from hospital. Objective: The aim of the present study was to examine the wellbeing of infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Methods: Approximately 4 weeks after birth, information on the feeding and sleeping patterns, skin color, infant elimination patterns and hydration, and Neonatal Abstinence Scores of infants (n = 7) exposed to buprenorphine via breast milk was collected via both observation and documentation. Results: Infants were progressing well, with normal sleep patterns and skin color, and 2 mothers had minor concerns regarding infant elimination patterns. Four infants were exclusively breastfed and 3 were receiving a supplement, with a range of 260 to 700 mL of formula over 24 hours. The sleep patterns following feeding ranged from 1.55 to 3.33 hours, with a median of 2.12 hours. Conclusion: No adverse effects were detected in infants exposed to buprenorphine via breast milk up to 4 weeks postnatal. Further research using larger samples to assess possible developmental effects over longer periods of time is required. 2014 Journal Article http://hdl.handle.net/20.500.11937/26075 10.1177/0890334413517748 Sage Science Press fulltext |
| spellingShingle | substance abuse drug-exposed infants infant health breastfeeding Gower, Shelley Bartu, Anne Ilett, K. Doherty, D. McLaurin, R. Hamilton, D. The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title | The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title_full | The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title_fullStr | The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title_full_unstemmed | The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title_short | The wellbeing of infants exposed to Buprenorphine via breast milk at 4 weeks of age |
| title_sort | wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age |
| topic | substance abuse drug-exposed infants infant health breastfeeding |
| url | http://hdl.handle.net/20.500.11937/26075 |